Liminatus Pharma, Inc.LIMN
LIMN on Nasdaq: biological products, (no diagnostic substances).
LIMN is the ticker for Liminatus Pharma, Inc., a healthcare company listed on Nasdaq operating in biological products, (no diagnostic substances).
A descriptive overview for LIMN is pending the next reference-data sync.
Sensei's call log on LIMN — entries, exits, and the chart-level reasoning.
Below is the outcome history for LIMN from Sensei's alert feed. Entry, target, and stop levels — plus the chart-level reasoning — are members-only.
- BUYAug 22, 2025No Fill
- BUYAug 22, 2025Hit+13.80%
- BUYJul 24, 2025No Fill
- BUYJul 24, 2025Hit+10.41%
Full details unlock inside the app
Common questions about this stock.
What is LIMN?
LIMN is the trading symbol for Liminatus Pharma, Inc., listed on Nasdaq in the healthcare sector.
What sector is LIMN in?
Liminatus Pharma, Inc. (LIMN) is classified in the healthcare sector — specifically biological products, (no diagnostic substances), based on its SEC SIC classification.
Has Sensei traded LIMN?
Yes — LIMN has appeared in the Sensei alert feed 4 times, including 2 calls that hit target. The "Sensei's calls on LIMN" section above lists the recent history; entry, target, and stop levels are members-only.
Where does LIMN trade?
LIMN trades on Nasdaq.
Is LIMN a stock or an ETF?
LIMN is a publicly-traded common stock, not an ETF.
Trade LIMN alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.